EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Mitochondrial Signature for Predicting Outcome of Early-Stage Breast Cancer by Machine Learning

Yanni Li, Kristina Sundquist, Xiao Wang, Jan Sundquist, Ashfaque A Memon

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2025.04.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Yanni Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Primary Health Care Research, Lund University, Region Skåne, Malmö, Sweden. Hauptthemen laut MEDLINE: Breast Neoplasms, Machine Learning, Biomarkers, Tumor, Mitochondria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, General Hospital of Malmö Foundation for the fight against cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Breast cancer, a leading female cancer worldwide, can be influenced by mitochondrial dysfunction. Dysregulation of mitochondria by the nuclear genome may cause breast cancer initiation and progression. However, the comprehensive investigation of mitochondrial-related genes as prognostic marker for the overall survival of early-stage breast cancer patients is still limited. METHODS: To address this, we employed machine learning methods to identify a concise set of mitochondrial-related genes with high accuracy and reliability in predicting survival outcomes. Bulk transcriptome collected from Sweden Cancerome Analysis Network - Breast (SCANB) was divided into training and testing datasets and the Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) was included as the external validation cohort. The 1136 known mitochondrial-related genes were analysed using univariate Cox regression, bootstrap and Lasso Cox regression in the SCANB training cohort for model construction. RESULTS: We identified a 14-gene mitochondrial signature that independently predicts the survival outcome of breast cancer (adjusted hazard ratio [HR]: 2.08, 95% confidence interval [CI]: 1.20-3.62) in the SCANB dataset. A highly predictive nomogram was further constructed by integrating the mitochondrial signature with clinical variables, enabling robust prediction of overall survival at 1-, 3- and 5-year. This model demonstrated strong predictive capability in both the training cohort (the area under the receiver operating characteristic [ROC] curve [AUC]: 0.84, 0.79, 0.78) and validation cohort (AUC: 0.92, 0.83, 0.78). CONCLUSION: In this study, we suggested a novel mitochondrial signature model by comprehensively analysing mitochondrial-related genes, which have the potential to accurately predict the clinical prognosis at the early stages of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMachine LearningBiomarkers, TumorMitochondriaHumansFemalePrognosisMiddle AgedTranscriptomeNomogramsSwedenNeoplasm StagingGene Expression Regulation, NeoplasticGene Expression ProfilingSurvival Rate

Stichwörter der Autor:innen

Breast cancerEarly diagnosisNomogramPrognosisTranscriptome

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Center for Primary Health Care Research, Lund University, Region Skåne, Malmö, Sweden.
  • Center for Primary Health Care Research, Lund University, Region Skåne, Malmö, Sweden; Skåne University Hospital, University Clinic Primary Care, Region Skåne, Malmö, Sweden; Center for Community-Based Healthcare Resear…
  • Center for Primary Health Care Research, Lund University, Region Skåne, Malmö, Sweden; Skåne University Hospital, University Clinic Primary Care, Region Skåne, Malmö, Sweden.
  • Center for Primary Health Care Research, Lund University, Region Skåne, Malmö, Sweden; Skåne University Hospital, University Clinic Primary Care, Region Skåne, Malmö, Sweden. Electronic address: ashfaque.memon@med.lu.se.

Förderung

  • Swedish Cancer Society
  • General Hospital of Malmö Foundation for the fight against cancer

Zitieren

APA

Li, Y., Sundquist, K., Wang, X., Sundquist, J., & Memon, A. A. (2025). The Mitochondrial Signature for Predicting Outcome of Early-Stage Breast Cancer by Machine Learning. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.04.020

Vancouver

Li Y, Sundquist K, Wang X, Sundquist J, Memon AA. The Mitochondrial Signature for Predicting Outcome of Early-Stage Breast Cancer by Machine Learning. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.04.020

BibTeX
@article{Li2025,
  author = {Li, Yanni and Sundquist, Kristina and Wang, Xiao and Sundquist, Jan and Memon, Ashfaque A},
  title = {The Mitochondrial Signature for Predicting Outcome of Early-Stage Breast Cancer by Machine Learning},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2025.04.020}
}
Kostenlos starten →